0001379006 false 0001379006 2023-05-25 2023-05-25 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

 

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, DC 20549

 

FORM 8-K

 

CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF

THE SECURITIES EXCHANGE ACT OF 1934

 

Date of report (Date of earliest event reported) May 25, 2023

 

NANOVIRICIDES, INC.
(Exact Name of Registrant as Specified in Its Charter)

 

Nevada 001-36081 76-0674577
(State or Other Jurisdiction of
Incorporation)		 (Commission File Number) (I.R.S. Employer Identification No.)
     
1 Controls Drive,
Shelton, Connecticut		 06484
(Address of Principal Executive Offices) (Zip Code)

 

(203) 937-6137
(Registrant's Telephone Number, Including Area Code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

 

¨ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
   
¨ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
   
¨ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
   
¨ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter). Emerging growth company ¨

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class:   Trading Symbol(s)   Name of each exchange on which registered:
Common Stock   NNVC   NYSE-American

 

 

 

 

 

 

Item 8.01.Other Events.

 

As previously disclosed, on February 7, 2023, the Board of Directors (the “Board”) and a majority of the Shareholders (the “Shareholders”) of NanoViricides, Inc. (the “Company”) approved a redomiciling of the Company (the ‘Redomicile”) wherein the Company will redomicile from a Nevada corporation to a Delaware corporation. The Redomicile will become effective on May 30, 2023 pursuant to Section 265 of the Delaware General Corporation Law and Sections 92A.120 and 92A.250 of the Nevada Revised Statutes. The Redomicile will occur according to the Plan of Conversion substantially in the form attached.

 

Item. 9.01.Financial Statements and Exhibits.

 

(d) Exhibits

 

Exhibit No. Description
2.1 Form of Plan of Conversion
104 Cover Page Interactive Data File (formatted as Inline XBRL)

 

 

 

SIGNATURES

 

PURSUANT TO THE REQUIREMENTS OF THE SECURITIES EXCHANGE ACT OF 1934, THE REGISTRANT HAS DULY CAUSED THIS REPORT TO BE SIGNED ON ITS BEHALF BY THE UNDERSIGNED THEREUNTO DULY AUTHORIZED.

 

  NANOVIRICIDES, INC.
   
     
Date: May 25, 2023 By: /s/ Anil Diwan
  Name: Anil Diwan
Title: Chairman, President

 

 

Grafico Azioni NanoViricides (AMEX:NNVC)
Storico
Da Apr 2024 a Mag 2024 Clicca qui per i Grafici di NanoViricides
Grafico Azioni NanoViricides (AMEX:NNVC)
Storico
Da Mag 2023 a Mag 2024 Clicca qui per i Grafici di NanoViricides